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 CHAPTER 1 
INTRODUCTION 
Over the course of human history, the source of the food that the population relies 
on for survival has changed dramatically (Jay, 2000).  Hunting and gathering have given 
way to the domestication of plants and livestock.  The growing of food for a family or a 
small region has been replaced by the centralization and globalization of food production.  
Growing crops in different parts of the country and the world has made fresh produce 
available at any time of year.  Rather than sitting down to a home cooked meal, 
consumers have turned to meals prepared outside the home or ready-to-eat (RTE) meals 
that require little to no preparation inside the home.  Health consciousness has led to a 
call for more natural foods, meaning less processing and a reduction in the addition of 
preservatives to food products.  These factors combine to make food safety not only a 
predominant issue to consumers but also more challenging than ever for those who 
produce these products.   
Food has long been recognized as a potential vector of disease.  For example, 
religious  restrictions on the consumption of pork were most likely put into place to 
protect against diseases associated with consumption of pork products (Hartman, 1997).  
As a consequence of the centralization of food production, religious and historical 
doctrine has been replaced by government regulation.  The inspection of meat was first 
introduced in the late 1800’s, followed by the Food, Drug, and Cosmetic Act in 1939, and 
the Food Additives Amendment in 1958 (Jay, 2000).  In the 1980s, the importance of 
food was recognized as a vector for several important pathogens; Listeria 
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 monocytogenes, Escherichia coli 0157:H7, and Campylobacter jejuni. The 1990’s thus 
saw enactment of increased surveillance measures and an increase in research towards 
the transmission pathways of food pathogens in order to further improve the safety of 
foods (Allos et al., 2004).  The Foodborne Disease Active Surveillance Network 
(FoodNet), established in 1996, is an effort between the Centers for Disease Control 
(CDC), the Department of Agriculture (FDA), and state health departments to monitor 
outbreaks of foodborne diseases (Allos, et al., 2004).  PulseNet uses molecular 
techniques to provide genetic fingerprints for food pathogens associated with 
contamination and outbreaks (Allos et al., 2004).  In 1997, Pathogen Reduction, Hazard 
Analysis and Critical Control Point (HACCP) were initiated, which calls for the 
identification and control of points in a process where bacterial contamination can occur 
(Allos et al., 2004). 
The initial 1997 FoodNet estimation for yearly cases of foodborne illness in the 
United States was 76 million cases, with 325,000 hospitalizations and 5500 deaths 
(Anonymous, 2006a).  Confirmed cases within the 15% of the population that FoodNet 
surveillance covers for the time period 1996-1998 was 24,511 cases of foodborne illness, 
with Campylobacter, Salmonella, and Shigella as the leading causative agents (Kennedy 
et al., 2000).  Differences between estimated and confirmed cases are most likely due to 
the large number of foodborne illnesses that go unreported every year due to mildness of 
symptoms and short duration of the illness.  The initial surveillance results for 2005 
shows a general reduction in laboratory confirmed cases of foodborne illness with only 
16,614 cases confirmed (Anonymous, 2006c).  Salmonella, Campylobacter, and Shigella 
are still the most commonly reported foodborne pathogens.  Though cases have declined 
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 every year since surveillance began, the rates of decline are slowing.  The 2005 report 
shows that Listeria levels, though down from 1996-1998, are higher than the lowest 
reported level in 2002 (Anonymous, 2006c).  Vibrio levels are actually on the rise.   
Though FoodNet data shows that cases of foodborne illness are declining, they 
still represent a substantial health care burden to the consumers and a monetary burden to 
the food industry.  When contamination is discovered in a product, the manufacturer is 
expected to voluntarily issue a recall notice.  The FDA can only act if the situation is 
urgent, in which case they request the manufacturer recall the product, typically followed 
by lawsuits and injunctions if the manufacturer refuses to follow the recommendations 
(Venugopal et al., 1996).  In 1991-1992, there were 230 recalls involving 569 products, 
138 (24%) were caused by microbial contamination (Venugopal et al., 1996).  Of these 
138 recalls, 90 (65%) involved L. monocytogenes.  Several large food recalls have 
occurred over the last few years.  In 2000, turkey and chicken deli meats were recalled in 
response to 29 cases of listeriosis which resulted in 4 deaths and 3 miscarriages 
(Anonymous, 2000).  Two years later 46 cases of listeriosis, resulting in 7 deaths and 3 
stillbirths prompted a recall of 24.7 million pounds of turkey and deli meats, the largest 
such recall in history (Anonymous, 2002).  Two high profile recalls have occurred in 
2006; a recall of 100% carrot juice prompted by 4 cases of botulism following 
consumption of heat abused juice, and the removal of all fresh bagged spinach from store 
shelves after 199 people across 26 states became infected with E. coli (Anonymous, 
2006b).  Along with the monetary loss involved with the recall of products, the presence 
of pathogens in the product also opens up the company to lawsuits by those who became 
infected. Even more importantly, a loss of trust in the brand name involved in the recall 
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 can permanently eliminate market shares the brand previously held and may even lead to 
bankruptcy of the producing company.   
Though not one of the most commonly found foodborne pathogens, the industry 
pays a great deal of attention to the Gram positive, non spore forming rod L. 
monocytogenes.  Initial FoodNet surveillance found that of the 99 deaths associated with 
food pathogens, 38 were caused by L. monocytogenes (Kennedy et al., 2000).  The high 
mortality rate associated with listeriosis, the name given to a range of symptoms 
associated with L. monocytogenes infection, is due to the severity of the disease.  L. 
monocytogenes is an invasive intracellular pathogen.  Following consumption, the 
organisms exit the intestines and are quickly engulfed by immune system macrophages 
(Rocourt and Cossart, 1997).  In individuals with normally functioning immune systems, 
the intracellular microorganism attracts the attention of cytotoxic T cells, which lyse the 
infected cell and expose the pathogen to further immune system attention (Parham, 
2000).  In individuals with suppressed immune systems, the elderly, pregnant women and 
their unborn children, and those with preexisting conditions that cause immune 
suppression, the bacteria is able to replicate and spread from cell to cell.  Those with 
active immune systems may suffer mild flu-like symptoms, if they suffer any symptoms 
at all.  Those who are immunocompromised can experience septicemia, bacteremia, 
meningitis, miscarriages, and stillbirths with a 20-30% mortality rate (Rocourt and 
Cossart, 1997). 
L. monocytogenes was linked to food following several outbreaks in the 1980’s.  
In 1983, 7 adult and 34 perinatal cases of listeriosis in Canada were traced to cole slaw 
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 that was later found to have been made with cabbage grown at a farm with known cases 
of ovine listeriosis (Schlech et al., 1983).  The largest known listeriosis outbreak 
occurred in Los Angeles in 1985.  142 cases of listeriosis, with 48 ensuing deaths, were 
traced back to the consumption of Mexican-style soft cheese tainted with unpasteurized 
milk (Linnan et al., 1988).  The second largest outbreak, 108 cases, with 14 associated 
deaths and 4 miscarriages/stillbirths, occurred in 1998-1999 and was linked to hot dogs 
from a facility in which the removal of a contaminated air conditioning unit caused post-
process contamination (Mead et al., 2005).  The outbreak ended with the recall of 35 
million pounds of product.  In response to these outbreaks, the United States adopted a 
zero tolerance policy for L. monocytogenes in ready to eat foods, instituted an emphasis 
on Good Manufacturing Practices (GMP), HACCP, recommendations for facility 
sanitation and safe handling of processed foods, and education for populations at risk for 
listeriosis (Shank et al., 1996). 
Controlling the growth of L. monocytogenes in a food production facility is 
challenging for manufacturers.  Many of the unprocessed products that come into the 
facility carry L. monocytogenes.  Franco et al. (1995) took samples from a poultry 
processing plant and found high levels of contamination, particularly on drumsticks, 96% 
of which showed counts exceeding 3 log CFU/g.  Beef and pork also come into the 
processing facilities carrying L. monocytogenes, with pork showing higher levels 
(Vandenelzen and Snijders, 1993).  Though the bacteria are often carried in the intestines 
(Thevenot et al., 2006), Autio et al. (2000) found that the tongue and tonsils are often the 
sources of carcass and facility contamination.  In sampling pork products processed in 
stores and in centralized facilities, the cuts that originated in the store and required the 
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 most handling showed the most microbial contamination (Duffy et al., 2001).  Listeria, in 
this case, was the most common source of contamination (26.7%).  Raw vegetables can 
also bring L. monocytogenes into a processing facility from any of a variety of sources, 
including decaying vegetation and feces used as fertilizer, the soil the plants grow in, or 
the water source for the crops (Beuchat, 1996). 
With nearly every raw product coming into a facility being a potential carrier of 
L. monocytogenes, it is up to the food processors to insure that all RTE products leave the 
facility free of contamination.  L. monocytogenes coming into the plant contaminates 
areas where raw products are processed (Franco et al., 1995; Thevenot et al., 2005).  
Frequent cleaning is used to control this contamination, but L. monocytogenes has shown 
resistance to some commonly used cleaning solutions and sanitizers (Taormina and 
Beuchat, 2002).  Resistance to sanitizers, including quaternary ammonium compounds, 
has been linked to the presence of mdrL, a gene that encodes an efflux pump (Romanova 
et al., 2002).  The inefficieny of cleaning procedures to remove L. monocytogenes has 
also been associated with its ability to adhere to stainless steel and form biofilms 
(Vatanyoopaisarn et al., 2000; Thevenot et al., 2006).  The complexity of the machinery 
used in production can also hinder the cleaning process, with bacteria growing in corners 
and crevices that are difficult to clean (Lunden et al., 2002). 
The difficulty in controlling L. monocytogenes levels in RTE food products lies in 
its resistance to many commonly used preservation methods.  Proper heating and 
pasteurization insures a Listeria-free product.  Improper heating, however, allows 
survival of the pathogen, which will continue to grow once the product is refrigerated 
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 (Samelis and Metaxopoulus, 1999).  Most L. monocytogenes contamination occurs 
following processing (Linnan et al., 1988; Reij and Den Aantrekker., 2004; Mead et al., 
2005).  Common routes of recontamination include improper packaging, unsanitary 
equipment, improper handling and storage, and the introduction of contaminated 
ingredients, like spices or flavorants (Reij and Den Aantrekker, 2004).  L. monocytogenes 
is psychrotrophic, meaning it can grow at low temperatures, making refrigeration 
selective for the growth of the organism.  It can also grow at high salt concentrations and 
in the presence of nitrates (Cole et al., 1990).  A survey of vacuum packaged processed 
meat showed that 53% of those surveyed were contaminated with L. monocytogenes, due 
to its ability to grow at low oxygen levels (Grau et al., 1992).  Antimicrobials, several of 
which are strong inhibitors of L. monocytogenes growth, are also used to control 
microbial growth in food products (Geise, 1994; Sofos et al., 1998).  Combinations of 
these preservation methods often have a synergistic effect, commonly referred to as the 
hurdle effect (Leistner et al., 2000). 
Recent consumer trends show an increased interest in more natural, less processed 
foods, which has turned research attention towards antimicrobial compounds that are 
found naturally in foods or produced naturally by microorganisms involved in food 
processing (Sofos et al., 1998).  The antimicrobials nisin and lysozyme are examples of 
such naturally produced compounds.  Bacteriocins are a class of peptides produced by 
lactic acid bacteria to inhibit the growth of similar bacteria, like L. monocytogenes, that 
compete for resources (Harris et al., 1989).  Nisin, a Class IIa bacteriocin, has been 
shown to be a strong inhibitor of L. monocytogenes growth (Ukuku and Shelef, 1997; 
Ennahar et al., 2000; Mota-Meira et al., 2000).  Nisin binds to the bacterial membrane 
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 via interaction between positively charged lysine residues in the nisin molecule and 
negatively charged phospholipid headgroups in the membrane (Abee, 1994; Moll et al., 
1997).  Following insertion into the membrane, transient pores are formed via a 
hydrophilic interaction between nisin molecules (Winkowski et al., 1996; Moll et al., 
1997).  Potassium ions are lost via these pores which causes depolarization of the 
membrane and loss of proton motive force (Abee et al., 1994).  Lysozyme, an enzyme 
found in eggs and milk, is a strong inhibitor of L. monocytogenes growth (Hughey and 
Johnson, 1987).  Lysozyme breaks down the peptidoglycan layer of Gram positive 
bacteria by hydrolyzing the 1,4 ß-D-linkage between N-acetylhexosamines (Proctor and 
Cunningham, 1988). 
The leveling of the rate of decrease in foodborne illnesses may suggest that the 
current technology available to prevent growth of pathogens in food products has reached 
its limit.  New technology may be needed to continue reducing the number of illnesses 
and recalls caused by foodborne pathogens.  Though antimicrobials like nisin and 
lysozyme are effective in inhibiting the growth of L. monocytogenes in laboratory media, 
their effectiveness is greatly reduced in actual food products due to interactions between 
the antimicrobial and the food constituents.  Lysozyme was less effective in reducing the 
numbers of L. monocytogenes in cheese and sausage compared to in fresh fruits and 
vegetables, likely due to interaction with fats in the cheese and sausage (Hughey et al., 
1989).  Nisin activity was shown to be greatly reduced in meat products due to 
interaction with glutathione in raw meats and nitrates and fats in bacon (Ghalfi et al., 
2006; Stergiou et al., 2006).   
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 The objective of this thesis is to develop a method by which antimicrobials are 
delivered into a food product as a concentrated dose to the specific area in which the 
microorganism is growing without interference from the food matrix.  More specifically, 
we plan to achieve this by delivering the antimicrobials nisin and lysozyme attached to 
nanoparticles and emulsion droplets.  We hypothesize that (a) the attachment to a 
delivery vessel may increase the local concentration of the antimicrobial in the vicinity of 
the bacterial pathogens and (b) that the size and charge of the nanoparticle following 
attachment of the antimicrobials will be critical to its efficacy against pathogens. This 
thesis is designed to test this hypothesis using silver nanoparticles with well defined sizes 
and surface chemistry that allow control over the loading of the particle and oil droplets 
to which nisin is a secondary layer attached to pork gelatin which acts as the primary 
emulsifier.
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 CHAPTER 2 
LITERATURE REVIEW 
Food Antimicrobials 
The traditional function of food antimicrobials or preservatives is to prolong shelf 
life and preserve quality of food through inhibition of spoilage microorganisms.  While 
food antimicrobials have been in use since ancient times, few are used exclusively to 
control the growth of specific foodborne pathogens.  An exception is nitrite, which has 
been used, in association with salt, ascorbate and erythorbate, and low pH, for hundreds 
of years to inhibit growth and toxin production of Clostridium botulinum in cured meats.  
More recently, other antimicrobials have been applied to foods against foodborne 
pathogens.  For instance, organic acids (e.g., lactic acid, acetic acid) have been employed 
as spray sanitizers against pathogens on beef carcasses.  Organic acid salts (e.g., sodium 
lactate, sodium diacetate) have been added to processed meats to inactivate pathogens 
(primarily L. monocytogenes).  Finally, nisin and lysozyme are approved for use in 
pasteurized processed cheese as a safeguard against growth and toxin production by C. 
botulinum and lactoferrin was recently approved to control E. coli O157:H7 in meats.  In 
most instances, the antimicrobial is part of a multiple intervention system that involves 
the chemical along with environmental (extrinsic) and food related (intrinsic) stresses and 
processing steps.  This has been termed “hurdle technology” or multiple interventions 
(Leistner and Gorris, 1995, Leistner, 2000). 
There are two arbitrary classifications of food antimicrobials, traditional or 
“regulatory approved” and naturally occurring (Davidson, 2001).  The former includes 
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 organic acids (acetic, lactic, propionic), sorbic acid, nitrites, sulfites, alkyl esters of p-
hydroxybenzoic acids (parabens) and some natural antimicrobials including lysozyme, 
nisin, natamycin and lactoferrin.  The latter includes compounds from microbial, plant 
and animal sources.  Using naturally occurring antimicrobials is desirable to the food 
industry for several reasons: (a) it is highly unlikely that new synthetic compounds will 
be approved for use as food antimicrobials due to the expense of toxicological testing, (b) 
there exists a significant need for expanded antimicrobial activity both in terms of 
spectrum of activity and of broad food application, (c) food processors are interested in 
producing “green” labels, i.e., ones without chemical names that apparently confuse 
consumers, and (d) there are potential health benefits that come with the consumption of 
some naturally occurring antimicrobials.  
Some of the most effective natural antimicrobials are extracted from spices and 
herbs, including Amaryllidaceae (e.g. garlic, onion) and members of the Cruciferae 
family (mustard, horseradish) (Davidson and Naidu, 2000; Sofos et al., 1998).  The 
chemical compositions of the active ingredients in these plants are diverse.  One 
commonality is that most of these compounds are oil-soluble and often derivatives of 
phenolic compounds.  The use of phenolic compounds is increasing because these 
components exhibit antimicrobial properties and have therapeutic and pharmaceutical 
applications as well. Extracts from dietary herb species belonging to the family 
Lamiaceae (mint family), including thyme, have been used as sources of medicine and 
food preservatives for over 4000 years.  Recently, some of the bioactive components 
linked to these medicinal and preservative functions have been determined to be phenolic 
metabolites (Peake et al, l991; Deighton et al, 1993; Deighton et al, l994).  Specific 
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 phenolic metabolites from Lamiaceae, like rosmarinic acid (from rosemary, spearmint, 
thyme and oregano) and thymol (from thyme and oregano), have both anti-inflammatory 
(Peake et al, l991) and antioxidant properties (Kuhnt et al, l995; Shapiro and 
Guggenheim, l995) in addition to their antimicrobial function.  These pharmacological 
functions may contribute to long-term cancer prevention due to their effectiveness as 
antioxidants.  
In the context of foodborne pathogens, the antimicrobial activity of the key 
metabolites of thyme, thymol and carvacrol, have been reported to inhibit the growth of 
Salmonella enteritidis, Staphylococcus aureus, E. coli and Vibrio parahaemolyticus 
(Katayama and Nagai, 1960; Beuchat, 1976).  A second class of natural antimicrobials, 
derived from animal sources, are the polypeptide antimicrobials (Sofos et al., 1998).  
Lysozyme, a lytic enzyme extracted from egg whites, is an example of this class of 
antimicrobials.  Other animal source enzymes, such as peroxidases and oxidases, and 
chelators, such as transferrins and lactoferrin, can inhibit microorganism growth as well 
(Payne et al., 1994; Branen and Davidson, 2000). Microorganisms themselves are also an 
abundant source of naturally occurring peptides that effectively inhibit the growth of a 
wide variety of foodborne pathogens and spoilage microorganisms.  The most promising 
of these are produced by members of the Lactococcus, Pediococcus, Lactobacillus, 
Leuconostoc, and Propionibacterium species. 
Limitations of Available Food Antimicrobial Systems 
A report published by Sofos et al. (1998) identified the following factors as major 
reason for the failure to implement widespread use of antimicrobials: (a) the efficacy of 
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 currently available antimicrobials in foods is low, (b) suitable antimicrobial delivery 
systems for commercial product formulations have not been developed, (c) large-scale 
extraction, isolation and production processes have not been pursued and (d) the 
toxicology and safety in food formulations has not been properly evaluated.  Low 
antimicrobial efficacy in actual food systems is the primary restriction on the extensive 
use of these substances by the food production industry.  At present, large quantities of 
traditional and naturally occurring food antimicrobials are needed to achieve even 
moderate reductions in growth rates of pathogenic organisms in food products (Davidson, 
2001). Large quantities do not only increase production costs considerably, they also 
negatively affect the sensory properties of the product (Sofos et al., 1998).  
The effectiveness of traditional antimicrobials is limited by pH and food 
component interactions.  For example, organic acids are only effective at low pH due to 
the fact that their antimicrobial activity is attributed to the undissociated acid form 
(Davidson, 2001).  Many of the compounds are also partially hydrophobic which causes 
them to interact with food lipids, making them less available for inhibition of 
microorganisms. A limitation of phenolic phytochemicals from food-grade herbs is the 
wide variation in their water-solubility characteristics.  Thymol, the major antimicrobial 
in thyme, is primarily hydrophobic and therefore insoluble in water, unlike simple 
hydroxylated phenolic acids which are primarily hydrophilic and therefore soluble in 
water.   Rosmarinic acid, another major phytochemical compound in thyme, is only 
partially soluble in cold water, but is fully soluble in a solution of hot water and ethanol.  
The plant and animal tissue from which we derive our food contains a variety of different 
microenvironments.  These microenvironments may be polar (e.g., aqueous solutions), 
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 non-polar (e.g., fat cells) or amphiphilic (e.g., membranes).  Thus, for a phenolic 
compound to exhibit beneficial properties in a plant, it must be located in a 
microenvironment where it is chemically active.  The phenolic compound, for example, 
may need to be located at the interface between the oil and water regions to demonstrate 
antioxidant or antimicrobial activity (Coupland and McClements, 1996).  Many of the 
key phenolic metabolites from herbs are ineffective as antimicrobials or antioxidants in 
foods because they have yet to be successfully incorporated into the appropriate 
microenvironment.  
Similar limitations are observed when using protein or phospholipid based 
antimicrobials such as lysozyme and nisin.  These compounds may also readily absorb at 
interfaces that are present in multiphase, multicomponent food systems, making them 
unable to interact with target microorganisms.  Furthermore, chemical interactions may 
take place that lead to structural and functional changes in the antimicrobials that render 
them inactive.  This chemical and physical instability, as well as the thermodynamically 
driven accumulation of the compounds in certain regions of the food product are key 
problems that reduce the efficacy of these otherwise potent compounds in foods. 
Encapsulation and Carrier Systems To Overcome Antimicrobial Deficiencies 
For many years the pharmaceutical industry has studied the encapsulation or 
surface adsorption of a variety of chemical compounds as a way of overcoming the 
difficulties involved in their delivery and their potential for causing unwanted side 
effects.  By encapsulating or surface adsorbing the compound, it can be protected from 
degradation and release a stronger dosage in a site specific manner that increases the 
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 potency of the drug while decreasing the amount needed.  The use of a 
carrier/encapsulation systems allows for breakdown of the particles and release of the 
encapsulated compound in a time dependent manner without the production of toxic 
breakdown products. 
The use and delivery of many compounds in food products have the same 
inherent difficulties.  Many compounds that give desirable flavors or structural properties 
to a product are unstable in the conditions that exist within the product or processing and 
storage conditions to which the product is exposed.  These compounds can undergo 
undesirable reactions with other ingredients or breakdown at high temperatures, high or 
low pH, or undergo hydrolytic breakdown via moisture in the product.  The use of 
antimicrobials that inhibit the growth of unwanted microorganisms in foods is also 
difficult due to the nature of the product and the antimicrobial.  Food antimicrobials, like 
nisin and lysozyme, are hydrophobic and as such end up sequestered in the lipid 
component of the food.  This drastically increases the amount of antimicrobial needed to 
show growth inhibition levels exhibited in laboratory growth medium.  Encapsulation of 
these compounds in  nano-sized particles or adsorption to their surfaces may allow some 
of these difficulties to be overcome.   
General Use of Encapsulation in the Food Industry 
Though the encapsulation of antimicrobial compounds for delivery in a food 
product has not yet been fully examined, the encapsulation procedure itself has been used 
in the food industry for many years.  Ingredient encapsulation has been examined to 
protect food constituents against damaging reactions like hydrolysis and oxidation, to 
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 enhance flavors by prolonging or controlling their release, to protect ingredients from 
damaging processing or cooking temperatures, and to mask the odor and flavor of 
nutritionally desirable compounds that have a less than desirable flavor profile (Dziezak, 
1988).  Food applications for these encapsulated ingredients encompass a wide variety of 
products, including but not limited to such varied products as dehydrated fruit juices, 
baked goods, meat products, and chewing gum.  For example, a major concern in the 
production of fruit juice powders and concentrates is the loss of volatile flavor 
components during the dehydration process.  By producing a cold pressed citrus oil 
encapsulated in a modified lipophilic starch, maltodextrin, or sugar, the desired flavor 
can be reintroduced into the powdered juice and give the resulting reconstituted juice a 
high percentage of the flavor found in fresh fruit juice (Bangs and Reineccius, 1990; 
Kopelman et al., 1977a; Anandaraman and Reineccius, 1986; Andres, 1977; Bhandari et 
al., 1992; Schulz et al. 1956).  Kopelman et al., (1977b) produced a reconstituted orange 
juice that retained 75% of the initial volatiles and water soluble aroma essences of the 
fresh juice by encapsulating them in a maltodextrin sucrose carrier.  Besides enhancing 
juice flavor, encapsulation also increases the shelf life of the volatile flavor components 
by protecting them against hydrolysis and oxidation (Anandarman and Reineccius, 1986; 
Bhandari et al. 1992).   
The beneficial effects of ingredient encapsulation are not limited to flavor 
constituents.  Ingredients desired for their functional properties or nutritional value can 
often lead to instability in the food product in which they are used.  Food acids are an 
important food constituent due to their use as flavoring agents, acidulants, preservatives, 
and texture modifiers.  The use of food acids is problematic, however, due to their 
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 hygroscopic nature, which causes caking in powdered products, and their undesired 
reactivity with flavor and color components.  The outer coating provided via 
encapsulation sequesters the acid, protecting it from water absorption and unwanted 
reactions with other ingredients, while protecting the beneficial aspects of the acid by 
releasing it into the product when it is most desired (Werner, 1980; Ciliberto et al., 
1981). Vitamin C, when used in baked goods, can react with other compounds, including 
iron and cinnamon, producing unwanted reaction products, and can cause yeast to begin 
producing carbon dioxide earlier than desired for proper product rising.  By 
encapsulating the vitamin C, unwanted reactions are avoided and the vitamin can be 
released when desired via time, heat, pH, or enzyme activity (Andres, 1977).  
Encapsulation can be used to protect the taste and appearance of a product, like meat, that 
would normally be altered by cooking or processing (Hoashi, 1986; Shahidi and Pegg, 
1991).  Hoashi (1986) attempted to replace the meat flavors lost in juices that escape 
during the cooking of meat products through the addition of calcium alginate gel 
encapsulated meat stocks and soups that burst and release flavor when the product is 
chewed.  Shahidi and Pegg (1991) stabilized the color of freshly cut meat via treatment 
with cooked-cured meat pigments encapsulated in food grade carbohydrates.  The color 
of the treated meat was comparable to meat treated with nitrite, but without the fear of the 
production of carcinogenic nitrosamines.  Encapsulation can also be used to protect 
against some unwanted flavors that are associated with the use of nutritionally valuable 
ingredients.  Thiamine, which gives food products a fishy, yeasty odor, was successfully 
encapsulated in a matrix of cellulose derivatives and hydroxylated lipids which allowed 
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 use of the nutrient in a bioavailable form without the less than desirable flavor and odor 
(Hall et al., 1980). 
In some cases, one food product will receive a great deal of attention from those 
who encapsulate ingredients, as is the case with chewing gum.  The goal of using 
encapsulation in chewing gum is twofold; providing stability to the relatively unstable 
sweeteners used in the gum whilst prolonging their sweet flavor (Cea et al., 1983; Wei et 
al. 1986; Yang et al., 1988; Schobel et al., 1986; Cherukuri et al., 1989; Cherukuri et al., 
1990; Hoashi, 1989; Levine et al., 1992).  Aspartame, the non-caloric sweetener of 
choice in many chewing gums due to the lack of a bitter aftertaste often associated with 
the use of certain artificial sweeteners, is unstable at high temperatures and prone to 
hydrolytic breakdown.  Several encapsulation methods have been proposed to overcome 
these shortcomings.  Cea, et al. (1983) proposed a variety of wall materials including 
cellulose ethers or esters, starches, gums, gelatin, vinyl polymers, and zeins to protect the 
aspartame.  Both low and high molecular weight polyvinyl acetate in combination with a 
hydrophobic plasticizer or an emulsifier have been proposed as encapsulation medium 
(Yang, 1988; Cherukuri et al., 1989).  The addition of the emulsifier is hoped to further 
protect the encapsulated sweetener by retarding the hydrolysis of the shell material 
(Cherukuri et al., 1989).  Schobel et al. (1986), on the other hand, proposed a 
hydrophobic polymer and hydrophobic plasticizer for similar reasons.  Wie et al. (1986) 
proposed a matrix of encapsulated sweetener in an elastomer, elastomer solvent, and wax 
shell would be best to prolong sweetness.  A second encapsulation step, which would 
provide an outer coating to the layer in which the aspartame is encapsulated, was 
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 suggested to improve stability and flavor release characteristics (Cherukuri et al., 1990; 
Levine et al., 1992).  
Metal Nanoparticles as Novel Carrier Systems 
Metal nanoparticles, constructed from metals such as gold, silver, and magnetic 
metals like iron oxide, have many potential uses in the biomedical field.  The 
antimicrobial activity of silver has long been utilized in the treatment of wounds and 
during surgical procedures to prevent bacterial infections (Fox Jr. et al., 1974; Bosetti et 
al., 2002; Alt et al., 2004).  The antimicrobial activity of silver is dependent upon it being 
present in its ionic form.  Silver ions interact with the cell membrane, competing with 
other compounds for binding sites, and internal compounds, particularly sulfur and 
phosphorous containing compounds, like DNA, which becomes condensed, preventing 
replication (Brown and Anderson, 1968; Doyle et al., 1980; Feng et al., 2000; Morones 
et al., 2005).  Silver nanoparticles able to produce ionic silver also demonstrate 
antimicrobial activity (Lee and Jeong, 2004; Morones et al., 2005; Cho et al., 2005; 
Sondi and Salopek-Sondi, 2004).  The apparent lack of toxicity of silver and silver ions 
combined with this antimicrobial activity makes incorporation of silver nanoparticles in 
bone cement and surgical devices a tool in combating nosocomial infections (Berger et 
al.¸1976; Bosetti et al., 2002; Alt et al., 2004; Lee and Jeong, 2004).  Silver nanoparticles 
have also shown antimicrobial activity against HIV-1 via post infection reduction in T-
cell apoptosis through an unknown mechanism (Sun et al., 2005). 
Gold nanoparticles also have a variety of potential uses, most dealing with the 
interaction between the functional group attached to the nanoparticle and another 
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 molecule.  Gold nanoparticles can be used gain insight into the mechanism by which a 
biochemical system functions, as seen with the binding of flavin, a cofactor in the 
flavoenzyme system (Bayir et al., 2006).  Binding the cofactor reduces it reduction 
potential, altering activity in the system.  IgG molecules attached to gold nanoparticles 
aid in the characterization of the interaction between the molecule and a target pathogen 
(Ho et al., 2004).  Attaching a molecule to a gold nanoparticle can alter its stability.  
Cytochrome c, when bound to mecapto-undecanoic acid functionalized gold 
nanoparticles increases its susceptibility to proteolysis (Worrall et al., 2006).  Attachment 
can also serve to strengthen a molecule, as in the case of stabilizing chymotrypsin at air-
water interfaces, protecting DNA from physical and enzymatic degradation, and 
stabilizing tetraaspartate peptide in water (Verma et al., 2004; Han et al., 2006a; Jordan 
et al., 2006).  The ability to bind DNA to functionalized gold nanoparticles may provide 
a vector for gene delivery for the purpose of gene therapy (Han et al., 2006a; Han et al., 
2006b; Goodman et al., 2006).  Han et al. (2006) showed that following binding, DNA 
can subsequently be released from the nanoparticle, in this case with light, and achieve a 
high level of transcription.  Gold nanoparticles can be used to exert control over 
enzymatic systems, whether by competing with the substrate for a binding site or by 
controlling the mechanism by which the enzyme regulates itself (You et al., 2006; 
Bayraktor et al., 2006). 
Several useful applications have also been devised for magnetic nanoparticles.  
The use of small magnetic particles has been examined for the cancer treatment known as 
hyperthermia, the raising of the temperature of cancerous cells to increase their 
susceptibility to chemotherapeutic agents.  A magnetic field can be used to cause the 
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 nanoparticles to oscillate, causing them to generate heat.  Smaller particles are able to 
generate greater heat in a given amount of time than larger ones (Bonder et al., 2006).  
Magnetic nanoparticles show potential as recoverable and reusable enzyme carriers 
(Tsang et al., 2006).  Attachment of β lactamase to iron oxide nanoparticles was achieved 
without blocking the enzyme active site, allowing the attached enzyme to be as accessible 
as a free enzyme, a trait that is lacking when enzymes are attached to other solid 
substrates (Tsang et al., 2006).  Magnetic nanoparticles can also be used as contrast 
agents in magnetic resonance imaging (MRI), a powerful medical diagnostic tool 
(Mornet et al., 2006).   
Nanoparticle Applications  
Nanoparticles as Antimicrobial Carrier Systems 
Nanoparticle systems can be used to overcome some of the difficulties inherent in 
using antimicrobials to treat bacterial and parasitic infection.  By encapsulating the 
antimicrobial, the need to flood the body with the compound while trying to maintain the 
delicate balance between minimum effective dose against the infection and maximum 
safe dose for the infected organism is removed (Langar and Peppas, 1981).  
Nanoparticles can be designed to deliver the antimicrobial compound to the site of the 
infection.  This is particularly useful in the case of intracellular pathogens such as L. 
monocytogenes and Salmonella Typhimurium.  Encapsulated antibiotics can be 
endocytosed by the cell, allowing for the delivery of antibiotics to the interior of 
phagocytic cells, a place most could normally not reach on their own.   
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 Nanoparticles synthesized using the polymer polyacrylamide have shown promise 
in the treatment of intracellular pathogens.  Polyacrylamide nanoparticles show a high 
binding capacity to several known antibiotics and are easily taken up by phagocytic cells 
(Courvreur et al., 1979).  This compound shows no toxicity at the cellular or whole 
organism level, only causing cell damage at levels above 1% (~2x104 particles/cell) 
(Kante et al., 1982).  Once introduced into an organism, polyacrylamide nanoparticles are 
quickly cleared from the bloodstream and accumulate in the liver (42.9%), the kidneys 
(5.42%) and the bone marrow (1.96%) (Krause et al., 1985).  The majority of the 
particles in the liver accumulate in the Kuppfer cells (Lenaerts et al., 1984).  Thus, this 
polymer meets the criteria set forth by Oppenheim (1981), they are non-toxic, 
biodegradable, and accumulate at the desired site of action. 
The ability of the nanoparticle to enter cells in which intracellular 
microorganisms have taken up residence allows for the release of antibiotics into areas 
that were formerly off limits to them.  By encapsulating ampicillin in 
polyisohexylcyanoacrylate (PIHCA) nanoparticles, Youssef et al. (1988) increased its 
therapeutic index 20 fold against a chronic L. monocytogenes infection in athymic nude 
mice.  The liver was completely sterilized after two 0.8 mg injections of PIHCA 
encapsulated ampicillin.  A 0.8 mg dose of ampicillin bound in PIHCA nanoparticles 
suppressed mortality in mice with acute fatal salmonellosis (Fattal et al., 1989).  This 
represents a 120-fold increase in the therapeutic index of ampicillin.  For unbound 
ampicillin, three 32 mg doses were needed to achieve the same results.  Complete 
sterilization of the liver was not achieved in the case of the Salmonella infection.  Other 
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 beta lactam antibiotics, including benzathine penicillin G, have also been encapsulated in 
nanoparticles and shown in vitro antimicrobial activity (Santos-Magalhaes et al., 2000).   
The cytotoxicity of the compound being used must be taken into affect when 
designing a nanoparticle system.  Fawaz et al. (1997) encapsulated the synthetic drug 
ciprofloxacin in polyisobutylcyanoacrylate (PIBCA) nanoparticles.  Ciprofloxacin is a 
member of the fluoroquinolones, antimicrobial agents believed to work via the inhibition 
of DNA gyrase.  The hydrophobicity of the compounds prevents their effectiveness 
against intracellular pathogens.  When testing these nanoparticles against a 
Mycobacterium avium infection in a human macrophage culture, it was found that though 
nanoparticle associated ciprofloxacin was more effective than unbound ciprofloxacin, it 
was much less so than anticipated (Fawaz et al., 1998).  This was most likely due to the 
cyotoxicity of the PIBCA itself at ciprofloxacin concentrations greater than 8 μg/ml (80 
μg/ml PIBCA) (Fawaz  et al., 1998).   
Nanoparticles as Vaccine Carriers 
To overcome the difficulties and limitations of parental vaccine delivery, micro- 
and nanoparticles have received extensive study as an alternate method of vaccine 
delivery.  Delivery of vaccine loaded nanoparticles to the mucosa or skin are viable 
alternatives to intramuscular injection.  By encapsulating the vaccine in a biodegradable 
polymer, it is possible to protect it from the harsh conditions in the stomach and thus 
deliver a vaccine orally.  Kofler et al. (1997) orally administered 800 nm PLGA 
nanoparticles loaded with LW 50020, an immunomodulator containing lysates of 7 
common respiratory pathogens, to BALB/c mice.  The particles were taken up by the 
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 Peyer’s Patches and mesenteric lymph nodes that line the small intestine.  The resulting 
immune response, consisting of increased levels of IgA and IgG, was significantly higher 
than the immune response following administration of comparable levels of free LW 
50020.  The uptake of orally administered chitosan nanoparticles by Peyer’s Patches has 
also been demonstrated (van der Lubben, 2001).  Oral delivery of the vaccines allows 
boosting of the immune response in the mucosa, the immune systems first line of defense 
against infection. 
The ability to encapsulate and deliver protein and DNA vaccines has also been 
demonstrated.  Radio labeled bovine serum albumin (BSA) was used to demonstrate the 
uptake of protein from nanoparticles in the small intestine (van der Lubben, 2001).  
Bivas-Benita et al. (2003) administered chitosan encapsulated Toxoplasma gondii GRA1 
protein and DNA vaccines orally to mice.  The mice showed increased production of 
IgG1 and IgG2a, immunoglobulins associated with an immune boosting TH2 response, 
as opposed to a protective TH1 response.  Oral administration of a plasmid encoding 8 
epitopes from Mycobacterium tuberculosis caused increased IFN-γ secretion in mice 
(Bivas-Benita et al., 2004).  The sub-400 nm particles elicited a stronger response than 
intramuscular vaccination with the plasmid.  In order to encapsulate DNA in PLGA 
nanoparticles, it is necessary to alter the charge of the polymer to avoid the use of harsh 
organic acids in the encapsulation procedure  (Kumar et al., 2004).  A blend of chitosan 
and PVAL was used to give a positive charge to the normally negatively charged 
nanoparticles.   
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 Nanoparticles have also proved useful in the relatively new area of vaccine 
delivery through the skin.  Chitosan nanoparticles (200nm) with internally encapsulated 
or surface attached plasmid DNA (pDNA) were topically applied to mice (Cui et al., 
2001).  The mice showed increased production of luciferase, which is encoded on the 
plasmid, after 24 hours at a higher level than in mice treated with naked pDNA.  The IgG 
titer of the nanoparticle treated mice increased after 28 days, significantly (32 fold) more 
than in mice treated with naked pDNA.  Kohli and Alpar (2004) determined that the 
charge density determined the ability of nanoparticles to move through the skin.  Particles 
with a large surface area (50 nm) or a large number of charged groups (500 nm) were 
successful in crossing the skin. 
Nanoparticles as Cancer Treament Vehicles 
Paclitaxel is a strong anti-tumor agent.  Its cytotoxicity is due to its ability to 
promote the formation of microtubules in cells (Rowinsky et al., 1990).  By disrupting 
the cells ability to control the growth and placement of microtubules, paclitaxel disrupts, 
among other things, the shape, motility, and ability to undergo mitosis (Rowinsky et al., 
1990).  The low water solubility of this compound has led to its delivery as Taxol®, a 
nonaqueous formulation containing the compound and the dehydrated alcohol 
Cremophor EL®.  There have been several documented cases of hypersensitivity to this 
compound.  Many researchers have turned to nanoparticles to overcome this limitation. 
Several research groups have produced nanoparticle encapsulated paclitaxel.  Mu 
and Feng (2002, 2003) produced paclitaxel nanoparticles using the polymer PLGA.  The 
resultant nanoparticles showed a biphasic release pattern, with a small burst release 
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 followed by a steady release (11% released after 30 days).  Burt et al. (1995) 
encapsulated the drug in a 50:50 mixture of PLA and ethelyene-vinyl acetate (EVA).  
This copolymer formulation had a high loading capacity (95-100% loading at 100 and 
1000 μg) and a slow release rate (15% released after 50 days).  Drug loaded PLA:EVA 
nanoparticles (6μg drug/ml polymer) showed localized activity in a chick chorioallantoic 
membrane (CAM) model.  The effectiveness of these nanoparticles in vivo would be 
lowered, however by the fact that they would be quickly removed from the blood stream 
as has been documented repeatedly with nanoparticles made with PLA as the polymer.  
In order to maintain a high level of nanoparticles in the bloodstream, paclitaxel was also 
encapsulated in PLA-MPEG nanoparticles (Dong et al., 2004).  The addition of MPEG to 
the nanoparticle surface increased the release rate dramatically (90% released over 14 
days), however. 
In vitro studies of PLGA encapsulated paclitaxel have been undertaken.  When 
tested against a human small cell lung cancer cell line (NCI-H69) showed that paclitaxel 
loaded PLGA nanoparticles showed a higher rate of activity than paclitaxel alone or as 
Taxol® (Fonseca et al., 2002).  A 25 μg/ml dose of Taxol® reduced the cancer cell 
viability 100%.  Paclitaxel loaded nanoparticles showed the same results with a dose of 
2.5 μg/ml, which represents a ten fold increase in efficacy.  The same amount of free 
paclitaxel only reduces the viability by 70%. 
Summary of Literature Review 
There are a wide range of antimicrobials available to control the growth of 
pathogenic bacteria, many of which are naturally found in foods or produced by 
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 microorganisms utilized in food production.  There exists an inherent difficulty in 
applying these compounds to food, however.  Nanoparticles, produced using compounds 
ranging from food grade chemicals to biodegradable polymers to metals, have long been 
used by the pharmaceutical industry to overcome similar difficulties in the delivery of 
therapeutic agents.  Though nanoparticles as a delivery vessel have been used to some 
extent to deliver or protect food ingredients, no work has been done to test their viability 
as delivery agents for food antimicrobials.  By using nanoparticles to deliver the 
antimicrobial compound into the food product, it may be possible to overcome the 
limitations that have deterred the use of such compounds in the past.   
 27
 CHAPTER 3 
MATERIALS AND METHODS 
Materials 
Carboxyl-terminated silver nanoparticles were purchased from Nanohorizons 
(University City, PA).  Nisin, corn oil, sodium hydroxide (NaOH), and hydrochloric acid 
(HCl) were purchased from Sigma Chemical Co. (St. Louis, MO).  200 Bloom Porkskin 8 
mesh gelatine was donated by Gelita (Souix City, IA).  L. monocytogenes strains J1-225, 
J2-020, J1-177, and C11-115 were obtained from the International Life Sciences Institute 
North America Listeria monocytogenes Strain Collection (Fugett et al., 2006).  
Escherichia coli strains 35150, 43895, 51685, and 700599 were purchased from the 
American Type Culture Collection (ATCC) (Manassas, VA).  Tryptic soy broth (TSB), 
tryptic soy agar (TSA), and yeast extract were purchased from BD Diagnostics (Franklin 
Lakes, NJ)  Double distilled and deionized water was used in all experiments.  
Attachment of Antimicrobials to Silver Nanoparticles 
Nisin and lysozyme were attached to the nanoparticles according to the method 
developed by Fischer et al. (2003).  Briefly, the antimicrobial and the silver nanoparticles 
were incubated together in distilled water at room temperature for 16 hours.  For the 
purpose of antimicrobial testing, the concentration ratio (in µg/ml) of nisin or lysozyme 
to silver was varied (1:0.167, 1:0.25, 1:0.5, 1:1, and 2:1) during the drug loading step.  
The concentration of nisin (5 µg/mL) or lysozyme (4 µg/mL) remained constant in each 
ratio while the concentration of silver nanoparticles varied.  Following antimicrobial 
loading, the size and charge of the antimicrobial/nanoparticle combination was measured 
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 using a Nano Series Zetasizer (Malvern Instruments).  Attachment of the antimicrobials 
to the gold nanoparticles will be attempted using the same protocol. 
ζ-Potential 
The ζ-potential was determined by placing 1 ml samples in a disposable cuvette. 
The cuvette was inserted into the measurement chamber of a particle electrophoresis 
instrument (Nano Series Zetasizer, Malvern Instruments, Worcestershire, UK). The ζ-
potential was then determined by measuring the direction and velocity that the particles 
moved in the applied electric field. The Smoluchowsky mathematical model was used by 
the software to convert the electrophoretic mobility measurements into ζ-potential 
values.   
Particle Size Determination 
The particle size distribution of nanoparticles was determined using a dynamic 
light scattering technique (Nano Series Zetasizer, Malvern Instruments, Worcestershire, 
UK). 1.0 ml samples, were placed in disposable cuvettes and inserted into the 
measurement chamber. The Sauter mean diameter (d32) of the samples was determined 
from the particle size distribution as:  
∑∑= ii
ii
Nd
Nd
d 2
3
32  (1) 
where N is the number of particles that had a particle diameter of d. 
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 Bacterial Growth Conditions 
Four strains of E. coli (F4546, H1730, E0019, and 932) and four strains of L. 
monocytogenes (Scott A, 310, 108, and 101) obtained from the University of Tennessee 
Department of Food Science and Technology culture collection were maintained at 4°C 
on tryptic soy agar (TSA) or tryptic soy agar with yeast extract (TSAYE) respectively.  
Tryptic soy broth (TSB) or tryptic soy broth with yeast extract (TSBYE) was inoculated 
with E. coli or L. monocytogenes and incubated at 32°C for 24 hours and subcultured for 
an additional 18 hours.  Cultures were diluted to approximately 104 CFU/mL prior to use.   
Antimicrobial Assay 
The antimicrobial activity of the nanoparticles and nanoparticle/antimicrobial 
combinations was determined via a microdilution assay in 96 well microtiter plates.  120 
µL of the bacteria in double strength TSB or double strength TSBYE and 120 µL of the 
silver nanoparticle solution were added to the wells.  Antimicrobial only controls and 
silver nanoparticles were tested via a 12 fold 1:1 dilution which allowed testing at 
concentration ranging from 215 µg/mL to 0.1µg/mL.  Silver nanoparticle/antimicrobial 
combinations were tested via a 5 fold 1:1 dilution series.  Microtiter plates were 
incubated at 32°C and 20°C.  Optical density readings were taken at 630 nm (OD630) at 
hours 0, 3, 6, 12, 24, and 48 using a BIO-TEK Automated Plate Reader.  Minimum 
inhibitory concentration (MIC) was determined as the lowest concentration at which no 
bacterial growth was observed.   
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 Emulsion Preparation  
An emulsifier solution was prepared by dispersing 0.5 wt % pork gelatin into 
water and gently heating to insure gelatin went into solution.  The solution was stirred 
overnight to insure hydration of the protein.  A primary emulsion was prepared by 
homogenizing 2 wt % corn oil with 98 wt % aqueous emulsifier solution in a blender 
followed by three passes through a microfludizer (Microfluidics 110L, Microfluidics 
Corp., Newton MA) at 9000 psi.  The pH of the emulsion was adjusted to pH 7 using 
NaOH and HCl solutions.  An aqueous nisin solution was prepared at a concentration of 
5120 μg/ml and the pH was adjusted to pH 7 using an NaOH solution.  The primary 
emulsion was diluted with the aqueous nisin solution to form secondary emulsions over a 
range of nisin concentrations. 
Antimicrobial Assay   
Four strains of E. coli (35150, 43895, 51685, and 700599) and four strains of L. 
monocytogenes (J1-225, J2-020, J1-177, and C11-115) were maintained at 4°C on TSA 
or tryptic soy agar with yeast extract (TSAYE) respectively.  TSB or tryptic soy broth 
with yeast extract (TSBYE) was inoculated with E. coli or L. monocytogenes and 
incubated at 32°C for 24 hours and subcultured for an additional 18 hours.  Cultures were 
diluted to approximately 104 CFU/mL prior to use. The minimum inhibitory 
concentration (MIC) of the double layered emulsion was determined according to the 
National Committee for Clinical Laboratory Standards (NCCLS, 1990) agar dilution 
method.  TSAYE was autoclaved and allowed to cool in a water bath until it reached a 
temperature of 50 ºC.  The double layered emulsion, the primary emulsion, and free nisin 
were added to the tempered agar at concentrations ranging from 128 μg/ml to 0.5 μg/ml.   
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 Bacteria were applied to the plate via spot inoculation.  Briefly, plates were inoculated 
with three 10 μL drops containing approximately 104 CFU/ml of the strains being tested.  
The plates were incubated at 32 ºC for 24 hours.  The MIC was recorded as the lowest 
concentration at which no growth was observed. 
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 CHAPTER 4 
ANTIMICROBIAL ACTIVITY OF SILVER NANOPARTICLES CARRYING 
NISIN AND LYSOZYME AGAINST ESCHERICHIA COLI O157:H7 AND 
LISTERIA MONOCYTOGENES 
Abstract 
The efficacy of nisin and lysozyme attached to silver nanoparticles against strains 
of Listeria monocytogenes (Scott A, 310, 108, and 101) and Escherichia coli (F4546, 
H1730, E0019, and 932) was investigated.  The effects of varying the antimicrobial to 
nanoparticle ratio and the effect of temperature on efficacy were tested.  Silver 
nanoparticles, which have been shown to have antimicrobial activities elsewhere, did not 
inhibit growth of any strain tested at any temperature.  The efficacy of nisin, a strong 
inhibitor of L. monocytogenes growth, was increased when attached to the nanoparticles.  
The antimicrobial/nanoparticle combination showed an increased efficacy at lower 
temperatures compared to growth at 32°C.  Lysozyme, also a strong inhibitor of L. 
monocytogenes growth, showed no antimicrobial activity against any strain when 
attached to the nanoparticles.  Neither antimicrobial inhibited E. coli growth when 
attached to the nanoparticles.  The change in antimicrobial activity of both nisin and 
lysozyme when attached to nanoparticles is attributed to the mechanism by which the 
antimicrobial inhibits growth. 
Introduction 
Food borne pathogens pose a significant health risk to consumers and a potential 
for lost capital to the food industry.  Though food producers go to great lengths to prevent 
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 microbial contamination of their products, the nature of the product and the growth 
capabilities of the organisms often defeat even their best efforts.  In 2005, nearly 17,000 
cases of food borne illness were identified in the FoodNet surveillance population 
(roughly 15% of the US population) (Anonymous, 2006c). Listeria infections, though 
lower than during the period lasting from 1996-1998, are up compared to the lowest 
known number of cases four years ago (Anonymous, 2006c).  Recent massive recalls of 
deli meats due to L. monocytogenes contamination (Anonymous, 2002) and fresh bagged 
spinach due to E. coli contamination (Anonymous, 2006d) show that continuing efforts 
are needed to insure the safety of the food supply. 
There are a number of antimicrobials available that inhibit the growth of food 
borne pathogens.  Several of these antimicrobials, like nisin and lysozyme, have GRAS 
(generally recognized as safe) status that allows for their use in certain food products. 
Unfortunately, these antimicrobials are far less effective in heterogeneous food products 
than they are in homogenous microbiological laboratory media.  Nisin activity, for 
example, has been shown to be greatly reduced in several meat products (Murray and 
Richard, 1997; Aasen et al., 2003; Grisi and Gorlach-Lira, 2005; Ghalfi et al., 2006; 
Stergiou et al., 2006).  Interfering food constituents include glutathione (Stergiou et al., 
2006), high salt concentration (Boziaris and Nychas, 2006), nitrates (Ghalfi et al., 2006), 
fat content (Benech et al., 2002b; Ghalfi et al., 2006), and proteolytic enzymes (Murray 
and Richard, 1997; Aasen et al., 2003). 
In order to effectively use these antimicrobials in a food product, it is necessary to 
deliver them in a manner by which the antimicrobial can interact with the microorganism 
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 without interference from the product itself.  Several novel delivery systems have been 
studied for this purpose.  The first type of delivery system involves the incorporation of 
antimicrobials into films that are then applied to a food surface.  Nisin has been 
incorporated into edible cellulose films (Coma et al., 2001), corn zein films (Hoffman et 
al., 2001), and polyethylene based plastic films (Siragusa et al., 1999).  Antimicrobial 
activity was maintained in each case.  The second delivery method involves the use of 
additional compounds as carriers of the antimicrobials.  Encapsulation in liposomes has 
been shown to increase the efficacy of nisin in laboratory media (Were et al., 2004) and 
in cheddar cheese (Benech et al., 2002a).  Surfactant micelles have also been shown to 
increase the antimicrobial efficacy of the essential oil components eugenol and carvacrol 
over a range of temperatures and pH (Gaysinsky et al., 2005a; Gaysinsky et al., 2005b). 
The pharmaceutical industry faces similar challenges in the delivery of 
antimicrobial compounds into their patients.  Compounds must be delivered in a dose 
potent enough to kill the microorganism, but mild enough to cause no harm to the patient 
(Langar and Peppas, 1981).  One strategy used to overcome this difficulty is the 
attachment of therapeutic agents to nanoparticles (Langer and Peppas, 1981; Oppenheim, 
1981; Soppimath et al., 2001).  A wide range of starting materials are used to construct 
the nanoparticles, from biodegradable polymers like polylactic acid (PLA) (Soppimath et 
al., 2001) to metals, like silver or gold (Sondi and Salopek-Sondi, 2004; Aymonier et al., 
2002). 
Nanoparticles have seen limited use in the food industry as a means to deliver 
ingredients into food products (Shahidi and Han, 1993).  Encapsulation methods can be 
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 used to protect volatile flavor components that are often lost when a product is heated or 
dried (Kopelman et al., 1997) or to allow an ingredient, like artificial sweeteners in gum, 
to be released slowly over time (Cherukuri et al., 1989).  It is the goal of this study to 
develop a nanoparticle delivery system for the food antimicrobials nisin and lysozyme.  
To this end, we will use nanoparticles made from silver, which in and of its self is known 
to have antimicrobial properties (Brown and Anderson, 1968; Zhao and Stevens, 1998; 
Sondi and Salopak-Sondi, 2004; Morones et al., 2005)  
Materials and Methods 
Attachment of antimicrobials to silver nanoparticles 
Carboxyl-terminated silver nanoparticles were purchased from Nanohorizons 
(University City, PA).  Nisin and lysozyme (MP Biomedicals, Aurora, OH) were 
attached to the nanoparticles according to the method developed by Fischer et al. (2003).  
Briefly, the antimicrobial and the silver nanoparticles were incubated together in distilled 
water at room temperature for 16 hours.  For the purpose of antimicrobial testing, the 
concentration ratio (in µg/ml) of nisin or lysozyme to silver was varied (1:0.167, 1:0.25, 
1:0.5, 1:1, and 2:1) during the drug loading step.  The concentration of nisin (5 µg/mL) or 
lysozyme (4 µg/mL) remained constant in each ratio while the silver concentration was 
varied.  Following antimicrobial loading, the size of the antimicrobial/nanoparticle 
combination was measured using a Nano Series Zetasizer (Malvern Instruments). 
Bacterial Growth Conditions. 
Four strains of E. coli (F4546, H1730, E0019, and 932) and four strains of L. 
monocytogenes (Scott A, 310, 108, and 101) obtained from the University of Tennessee 
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 Department of Food Science and Technology culture collection were maintained at 4°C 
on tryptic soy agar (TSA) or tryptic soy agar with yeast extract (TSAYE) (Difco, Detroit, 
MI) respectively.  Tryptic soy broth (TSB) or tryptic soy broth with yeast extract 
(TSBYE) (Difco, Detroit, MI) was inoculated with E. coli or L. monocytogenes and 
incubated at 32°C for 24 hours and subcultured for an additional 18 hours.  Cultures were 
diluted to approximately 104 CFU/mL prior to use.   
Antimicrobial Assays 
The antimicrobial activity of the nanoparticles and nanoparticle/antimicrobial 
combinations was determined via a microdilution assay in 96 well microtiter plates.  120 
µL of the bacteria in double strength TSB or double strength TSBYE and 120 µL of the 
silver nanoparticle solution were added to the wells.  Antimicrobial only controls and 
silver nanoparticles were tested via a 12 fold 1:1 dilution which allowed testing at 
concentration ranging from 215 µg/mL to 0.1µg/mL.  Silver nanoparticle/antimicrobial 
combinations were tested via a 5 fold 1:1 dilution series.  Microtiter plates were 
incubated at 32°C and 20°C.  Optical density readings were taken at 630 nm (OD630) at 
hours 0, 3, 6, 12, 24, and 48 using a BIO-TEK Automated Plate Reader.  Minimum 
inhibitory concentration (MIC) was determined as the lowest concentration at which no 
bacterial growth was observed.  All assays were run in duplicate. 
Results 
Size of Silver Nanoparticles with Attached Antimicrobials.   
The sizes of the silver nanoparticles with attached nisin and lysozyme are shown 
in Table 1.  The silver nanoparticles without the attached antimicrobial range in size from 
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 20-30 nm.  The nanoparticles with attached nisin ranged in size from around 280-340 nm.  
The nanoparticles with attached lysozyme were smaller, ranging in size from 45-160 nm.  
Both antimicrobials showed an increase in size as the concentration ratio decreased from 
6:1 to 2:1 (290 to 337 nm with nisin, 45 to 160 nm with lysozyme), a decrease in size 
from 2:1 to 1:1 (337 to 283 nm with nisin, 160 to 60 nm with lysozyme), and an increase 
in size from 1:1 to 1:2 (283 to 329 nm with nisin, 60 to 140 nm with lysyozyme). 
Antimicrobial Activity of Silver Nanoparticles  
Figure 1 shows the growth of L. monocytogenes Scott A (A) and E. coli strain 
H1730 (B) in the presence of silver nanoparticles at 32°C.  No growth inhibition was 
observed in either strain at silver concentrations up to 215 μg/mL.  Both strains showed 
growth levels comparable to bacteria only controls (data not shown).  These results are 
typical for all strains tested at either temperature.   
Antimicrobial Activity of Nisin Attached to Silver Nanoparticles 
Table 2 shows the MIC’s obtained in the antimicrobial assays performed with 
nisin and nisin attached to silver nanoparticles.  Nisin alone inhibited growth of three 
strains of L. monocytogenes at a concentration of 21 μg/mL, with Scott A being the most 
resistant strain with an MIC of 41 μg/mL.  When loaded, the silver nanoparticles, at the 
highest concentration, were only loaded with a 5 µg/ml dose of nisin.  Any inhibition 
would therefore be seen as an increase in efficacy.  The efficacy of the silver 
nanoparticle/nisin combination increased against three strains, 101 (Figure 2A), 310 
(Figure 2B), and 108.  Scott A (Figure 2C) was again the most resistant strain.  Nisin is 
not a strong inhibitor of E. coli growth and attachment did not increase its ability to 
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 inhibit growth.  There was, however, a reduction in strength of growth seen in strain 
F4546 (Figure 2D).  Reduction of the antimicrobial to nanoparticle ratio caused a 
decrease in efficacy against three of the four L. monocytogenes strains.  Only strain 101 
did not show decreased efficacy when the nisin to silver ratio was decreased.  There was 
a marked increase in antimicrobial activity of the silver nanoparticles with attached nisin 
at 20°C against both L. monocytogenes and E. coli when compared to the activity at 32°C 
(Figure 3).  
Antimicrobial Activity of Lysozyme Attached to Silver Nanoparticles 
Lysozyme did not inhibit the growth of L. monocytogenes and E. coli at high or 
low temperature when attached to the silver nanoparticles.  Lysozyme is a strong 
inhibitor of L. monocytogenes growth.  The typical MIC of lysozyme against L. 
monocytogenes was found to be 2.5 μg/mL.  Strain 101 was the most susceptible to 
lysozyme, with an MIC of 0.5 μg/ml.  Nanoparticles were prepared with a starting 
lysozyme concentration of 4 μg/mL, a concentration high enough to inhibit growth in all 
strains testd.  When attached to silver nanoparticles, lysozyme lost the ability to inhibit 
the growth of these organisms (data not shown).  Temperature did not effect the efficacy 
of the lysozyme/nanoparticle combinations.  Lysozyme, which is not a strong inhibitor of 
E. coli growth, did not inhibit growth of any strain of E. coli at any antimicrobial to silver 
nanoparticle ratio tested at either temperature. 
Discussion 
Silver nanoparticles were chosen as a delivery system for food antimicrobials due 
to the long known antimicrobial activity of silver (Russell and Hugo, 1994).  This 
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 antimicrobial activity has been exploited in the medical profession to prevent infection on 
burns wounds and in association with surgical implants (Fox et al., 1974; Bosetti et al., 
2002; Alt et al., 2004) and has been examined as a packaging implement to reduce 
bacterial growth in apple juice (Nobile et al., 2004).  The silver nanoparticles in our 
study showed no antimicrobial activity against L. monocytogenes or E. coli. 
The antimicrobial activity of silver is dependent on its state.  Though the 
mechanism of action is not completely understood, the antimicrobial activity of silver is 
attributed to it being in its ionized state.  Silver ions being positively charged have been 
shown to bind to negatively charged compounds such as peptidoglycan, techoic acid, and 
protein thiol groups, disrupting membrane and protein activity in the cell (Doyle et al., 
1980; Beveridge and Murray, 1980; Feng et al., 2000).  The silver nanoparticles used in 
this study, with attached carboxyl group, were not used at a pH which would allow them 
to exist in an ionic state. Thus the absence of any antimicrobial activity is not a surprise.  
Interestingly, Sondi and Salopek-Sondi (2004) showed that silver nanoparticles, 
regardless of charge, inhibited E. coli growth.  This activity was limited to solid media.  
Nanoparticles in liquid media only delayed growth, which resumed as nanoparticles were 
removed from the media via interaction with dead cellular material.  Though no such 
growth delay was noted in this case, solid media was not used to determine if the liquid 
media was in fact reducing antimicrobial activity.  Panàček et al. (2006) demonstrated 
that silver nanoparticle size effects antimicrobial activity.  The relative uniform size of 
the nanoparticles used in this study did not allow this to be examined.   
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 Lysozyme, an enzyme that occurs naturally in many food products, inhibits the 
growth of Gram positive bacteria by hydrolyzing the 1, 4 ß-D-linkage between N-
acetylhexosamines in the peptidoglycan layer (Proctor and Cunningham, 1988).  
Lysozyme inhibited L. monocytogenes at low concentrations.  E. coli growth was not 
inhibited by lysozyme, which is not an effective inhibitor of Gram negative bacterial 
growth due to the protection provided by lipopolysaccharide in the outer membrane 
(Ohno and Morrison, 1989).  When attached to silver nanoparticles, lysozyme showed no 
inhibitory activity against any strain of L. monocytogenes or E. coli at any concentration 
ratio or temperature tested.  This is likely due to the interaction between the enzyme and 
the nanoparticle blocking or altering the active site of the enzyme in such a way that the 
enzyme activity is lost.  Fischer et al. (2002) found that similarly binding the enzyme α-
chemotrypsin to gold nanoparticles led to the eventual denaturation of the enzyme. 
Like lysozyme, nisin, which is a strong inhibitor of Gram positive bacterial 
growth, is not effective in controlling the growth of Gram negative bacteria.  Herein, 
nisin did not inhibit the growth of any E. coli strain.  Attachment of nisin to sliver 
nanoparticles did not enhance it efficacy against E. coli at 32°C.  Two strains, E0019 and 
F4546, were, however inhibited at lower temperatures.  A marked increase in efficacy 
was observed against L. monocytogenes.  Growth inhibition was observed when silver 
nanoparticles loaded with as little as 5 µg/mL of nisin, a 4 fold increase in efficacy when 
compared to nisin alone. 
This increased efficacy may also be explainable via the mechanism by which 
nisin inhibits growth.  Nisin inhibits bacterial growth by forming pores in the bacterial 
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 membrane, which causes ATP efflux, reduced intracellular ATP concentration, and a 
dissipated proton motive force (Winkowski et al., 1996).  Pore formation is accomplished 
via the barrel-stave method (Ojcious et al., 1991).  Briefly, the amphiphilic nisin 
molecule attaches to the membrane through interactions between the negatively charged 
phospholipid head groups and the positive arginine residues in the nisin molecule.  The 
nisin molecules are pulled into the membrane where they float around until contact with 
other nisin molecules via hydrophobic interaction causes formation of transient pores 
(Winkowski et al., 1996).  The assumed ability of the silver nanoparticles to deliver a 
more concentrated dose of nisin molecules to a smaller area of the membrane increases 
the likelihood of nisin-nisin interaction and thus pore formation in the membrane. Figure 
4 demonstrates this proposed mechanism of action.  This increased interaction would 
allow increased efficacy against the bacterium with a smaller initial dose.   
Increased efficacy of nisin and nisin/nanoparticle combinations was observed at 
lower temperatures.  This is a commonly observed phenomenon when antimicrobials are 
used to inhibit L. monocytogenes growth at low temperatures.  Membrane fluidity and 
phospholipids content have been shown to affect the efficiency of nisin (Mazzotta and 
Montville, 1997; Crandall and Montville, 1998; Ming and Daeschel, 1993; Li et al., 
2002).  Juneja and Davidson (1993) observed similar results with propyl paraben.  The 
ability of L. monocytogenes to grow at low temperatures is due, at least in part, to the 
ability to change the fatty acid composition of the membrane of fluidity, in effect 
increasing the membrane fluidity (Annous et al., 1997). 
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 Varying antimicrobial to nanoparticle concentrations were used to determine the 
effect of the nanoparticle charge on antimicrobial activity.  Some decrease in efficacy 
was observed when nanoparticle to antimicrobial concentration increased.  It is thought 
that this is due to repulsion between the negatively charged head groups in the 
membrane.  More experiments will be needed to determine how the antimicrobial is 
loading on the nanoparticle and in turn interacting with the membrane to fully understand 
the effects of the nanoparticle delivery.  Further studies will also be needed to determine 
if the increased efficacy demonstrated in this study will occur in an actual food product. 
Conclusions 
Silver nanoparticles were examined for their ability to deliver the food 
antimicrobials nisin and lysozyme.  Attaching nisin to the nanoparticles increased its 
efficacy, suggesting that silver nanoparticles are a potential delivery mechanism for this 
antimicrobial.  Lysozyme, however, lost its ability to inhibit microbial growth when 
attached to the nanoparticles.  Further research is needed to characterize the interaction 
between the antimicrobial, nanoparticle, and microorganism.  The ability of this 
increased efficacy to be duplicated in an actual food product will also be examined.   
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 CHAPTER 5 
DOUBLE LAYER EMULSION DROPLETS AS A POTENTIAL DELIVERY 
VESSEL FOR THE FOOD ANTIMICROBIAL NISIN 
Abstract 
Layer-by-layer deposition is the process by which alternating layers of positively 
and negatively charged particles are deposited on a charged surface to form thin film 
structures.  This technique has also proven useful in the building of layers of charged 
emulsifiers on the surface of emulsion droplets, conferring added protection against 
aggregation in the face of changes in temperature, pH, salt concentration, and moisture 
content, as well as improved protection against lipid oxidation.  Using the layer-by-layer 
deposition technique, we created a double layered emulsion in which the second layer 
was composed of the food antimicrobial nisin.  This antimicrobial, though a potent 
inhibitor of the foodborne pathogen Listeria monocytogenes in laboratory media, often 
proves ineffective in food products due to interactions with food constituents reducing 
the antimicrobial activity of the molecule.  The goal of this project was to use the double-
layered emulsion as a delivery system to overcome this deficiency.  Binding the nisin to 
the emulsion droplet, however, decreased its antimicrobial activity substantially, most 
likely due to strong interactions with the primary protein emulsifier or a reduction in the 
charge of the nisin molecule itself as part of the attachment process.  The addition of 
EDTA, which has been shown to increase effectiveness of certain antimicrobials against 
Gram-negative bacteria, had no effect on the efficacy of the nisin loaded emulsion 
droplets. 
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 Introduction 
Decher and Hong (1991a) described layer-by-layer deposition as a technique by 
which thin films of alternating layers of positively and negatively charged molecules are 
deposited onto a charged surface via electrostatic interactions.  These molecules, whether 
bipolar amphiphiles or multipolar electrolytes, can be brought onto the charged surface 
by dipping the surface into aqueous solutions containing the charged molecules (Decher 
and Hong, 1991a; Decher and Hong, 1991b).  The layer-by-layer deposition process has 
been used to build multilayer films on solid micro- and nanosized particles as well as flat 
surfaces (Pommersheim et al., 1994; Caruso et al., 1998; Sukorukov et al., 1998; Caruso 
and Möhwald, 1999a; Caruso and Möhwald, 1999b).  This method allows for the 
building of functionalized surfaces on particles with nanometer-level control over the 
thickness of the deposited layer (Pommersheim et al., 1994; Caruso and Möhwald, 
1999a).  One key use of this technique is to design particles that exhibit biological 
activity, including attachment of antibodies like immunoglobulin G (IgG) and fluorescent 
labels for immunoassays or the attachment of active enzymes for variety of enymatic 
reactions (Pommersheim et al., 1994; Yang et al., 2001).   
The application of the layer-by-layer technique to emulsion droplets makes this 
technique potentially useful to the food industry (Guzey and McClements, 2006).  In the 
formation of multiple layered emulsions, a primary emulsion is first created by 
homogenizing oil, water, and a charged emulsifier, which acts as the first layer.  The 
second layer is added by diluting the primary emulsion in an aqueous solution containing 
oppositely charged molecules that will attach to the primary charged emulsifier (Ogawa 
et al., 2003a).  The addition of two or more layers to the oil droplet conveys stability 
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 against aggregation in the presence of environmental stresses encountered during the 
processing of the food product, including changes in temperature, salt concentration, pH, 
and moisture content (Aoki et al., 2005; Klinkersorn et al., 2005a; Surh et al., 2005).  
Coating the oil droplets with multiple layers of emulsion droplets has also been shown to 
slow lipid oxidation (Ogawa et al., 2003; Klinkerson et al., 2005a).  The goal of this 
study was to use the layer-by-layer deposition technique to assemble emulsion droplets 
with nisin, a generally recognized as safe (GRAS) antimicrobial, as the secondary 
emulsifier for the purpose of antimicrobial delivery. 
 Nisin is a bacteriocin, a peptide produced by lactic acid bacteria to inhibit the 
growth of similar bacteria that compete for their resources, such as the foodborne 
pathogen Listeria monocytogenes   (Harris et al., 1989; Ukuku and Shelef, 1997; Ennahar 
et al., 2000; Mota-Meira et al., 2000).  Ethylenediaminetetraacetic acid (EDTA), used in 
conjunction with several antimicrobials, including nisin, has been shown to have a 
synergistic effect in regard to the efficacy of the antimicrobial against foodborne Gram-
negative pathogens like E. coli via disruption of the outer membrane (Jay, 2000; Branen 
and Davidson, 2004; Lambert et al., 2004).  L. monocytogenes is problematic to food 
manufacturers in that it can grow at low temperatures, at high salt concentrations, and at 
low oxygen levels, nullifying many of the methods by which manufacturers limit the 
growth of microorganisms in their products (Cole et al., 1990; Grau et al., 1992; Samelis 
and Metaxopoulus, 1999).  Though nisin inhibits the growth of this organism, its use in 
food products is limited due to the loss of efficacy caused by interactions between nisin 
and the constituents of the food matrix into which it is introduced (Murray and Richard, 
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 1997; Aasen et al., 2003; Grisi and Gorlach-Lira, 2005; Boziaus and Nychas, 2006; 
Ghalfi et al., 2006; Stergiou et al., 2006). 
To overcome the loss of antimicrobial activity due to the interference of the food 
product itself, research has turned to the development of delivery systems to deliver the 
antimicrobial into the product in a way that it still remains active against the target 
pathogens.  Several novel delivery systems have been studied for this purpose.  The first 
type of delivery system involves the incorporation of antimicrobials into films that are 
then applied to a food surface.  Nisin has been incorporated into edible cellulose films 
(Coma et al., 2001), corn zein films (Hoffman et al., 2001), and polyethylene based 
plastic films (Siragusa et al., 1999).  Antimicrobial activity was maintained in each case.  
The second delivery method involves the use of additional compounds as carriers of the 
antimicrobial.  Encapsulation in liposomes has been shown to increase the efficacy of 
nisin in laboratory media (Were et al., 2004) and in cheddar cheese (Benech et al., 2002).  
Surfactant micelles have also been shown to increase the antimicrobial efficacy of the 
essential oil eugenol over a range of temperatures and pH (Gaysinsky et al., 2005a; 
Gaysinsky et al., 2005b).  By attaching nisin to a primary emulsifier, in this case the 
protein pork gelatin, we hypothesized that emulsion droplets may act as a delivery 
vehicle for nisin and thus overcome the difficulties inherent in the use of this 
antimicrobial in a food system.   
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 Materials and Methods 
Materials   
Nisin, corn oil, sodium hydroxide (NaOH), hydrochloric acid (HCl), and EDTA 
were purchased from Sigma Chemical Co. (St. Louis, MO).  200 Bloom Porkskin 8 mesh 
gelatine was donated by Gelita (Souix City, IA).  Distilled and deionized water was used 
for the preparation of all solutions.  L. monocytogenes strains J1-225, J2-020, J1-177, and 
C11-115 were obtained from the International Life Sciences Institute North America 
Listeria monocytogenes Strain Collection (Fugett et al., 2006).  Escherichia coli strains 
35150, 43895, 51685, and 700599 were purchased from the American Type Culture 
Collection (ATCC) (Manassas, VA).  Tryptic soy broth (TSB), tryptic soy agar (TSA), 
and yeast extract were purchased from BD Diagnostics (Franklin Lakes, NJ). 
 
Emulsion Preparation   
An emulsifier solution was prepared by dispersing 0.5 wt % pork gelatin into 
water and gently heating to insure gelatin went into solution.  The solution was stirred 
overnight to insure hydration of the protein.  A primary emulsion was prepared by 
homogenizing 2 wt % corn oil with 98 wt % aqueous emulsifier solution in a blender 
followed by three passes through a microfludizer (Microfluidics 110L, Microfluidics 
Corp., Newton MA) at 9000 psi.  The pH of the emulsion was adjusted to pH 7 using 
NaOH and HCl solutions.  An aqueous nisin solution was prepared at a concentration of 
5120 μg/ml and the pH was adjusted to pH 7 using NaOH and HCl solutions.  The 
primary emulsion was diluted with the aqueous nisin solution to form secondary 
emulsions over a range of nisin concentrations. 
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Particle Size and ζ -Potential Measurement   
Particle size and ζ- potential measurements were conducted using a Nano Series 
Zetasizer (Malvern Instruments).  Concentrated emulsions were diluted to a 
concentration of approximately 0.005 wt % prior to measurement.  Mean particle 
diameters were calculated as the average of three measurements with standard deviation.  
The ζ- potential measurements are reported as the average and standard deviation of three 
measurements. 
 
Antimicrobial Assay 
Four strains of E. coli (35150, 43895, 51685, and 700599) and four strains of L. 
monocytogenes (J1-225, J2-020, J1-177, and C11-115) were maintained at 4°C on TSA 
or tryptic soy agar with yeast extract (TSAYE) respectively.  TSB or tryptic soy broth 
with yeast extract (TSBYE) was inoculated with E. coli or L. monocytogenes and 
incubated at 32°C for 24 hours and subcultured for an additional 18 hours.  Cultures were 
diluted to approximately 104 CFU/mL prior to use.  The minimum inhibitory 
concentration (MIC) of the double layered emulsion was determined according to the 
National Committee for Clinical Laboratory Standards (NCCLS, 1990) agar dilution 
method.  TSAYE was autoclaved and allowed to cool in a water bath until it reached a 
temperature of 50 ºC.  The double layered emulsion, the primary emulsion, and free nisin 
were added to the tempered agar at concentrations ranging from 128 μg/ml to 0.5 μg/ml.  
EDTA was added to plates at concentrations ranging from 2048 μg/ml to 8 μg/ml.  EDTA 
was added to the double layered emulsion dilution series at 512 μg/ml and 256 μg/ml. 
 49
 Bacteria were applied to the plate via spot inoculation.  Briefly, plates were inoculated 
with three 10 μL drops containing approximately 104 CFU/ml of the strains being tested.  
The plates were incubated at 32 ºC for 24 hours.  The MIC was recorded as the lowest 
concentration at which no growth was observed. 
 
Results 
Formation of double-layered emulsions   
Double layered emulsions were produced using the layer-by-layer depositioning 
technique.  The attachment of the second layer, the nisin, to the primary emulsifier pork 
gelatin was determined via ζ- potential measurements.  When an oppositely charged 
polymer is attached to the first layer, a reversal in the surface charge can typically be 
observed (Caruso et al. 1998).  Figure 5 shows ζ- potential measurements taken across a 
pH range for the primary emulsion (A) and the aqueous nisin solution (B).  In order to 
attach positively to charged emulsion droplets stabilized by gelatin, nisin in the aqueous 
solution must carry a negative charge.  Figure 5(B) indicates that the isoelectric point (pI) 
of nisin is approximately pH 5. Thus nisin was added to the pork gelatin emulsions at pH 
7 to obtain dual layered emulsion droplets. At pH 7 pork gelatin carruer a strongly 
positive charge while nisin carries a slightly negative charge.  The ζ- potential emulsion 
droplets stabilized by pork gelatin as a function of added nisin is shown in Figure 6.  The 
addition of the negatively charged nisin caused a strong decrease in the positive charge of 
the emulsion droplet suggesting at least a partial, if not full coverage of the positively 
charged primary emulsion layer.  A slight increase in droplet size was also observed 
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 following addition of the nisin solution, from an average diameter of 322.33 ± 8.32 nm to 
338.33 ± 13.05 nm, which is characteristic after adsorption of a secondary layer. 
  
Antimicrobial Assays   
The results of the agar dilution assay are shown in Table 3.  Dilutions were 
prepared from an initial stock solution containing the emulsion plus nisin at a 
concentration of 1024 µg/ml, representing the concentration of nisin which caused the 
greatest amount of charge reduction in the primary protein emulsion layer (Figure 5).  
Nisin, not normally a strong inhibitor of E. coli growth, did not inhibit the growth of any 
strain tested at either pH whether alone or as the secondary layer on the corn oil droplet.  
Nisin alone inhibited three of the four L. monocytogenes strains tested, with strain J2-020 
showing resistance to the highest nisin concentration tested.  The results in Table 3 show, 
however, that corn oil droplets with a positively charged protein as the primary emulsifier 
did not act as a delivery vessel of antimicrobially active nisin.  The highest concentration 
of nisin in combination with the emulsion droplets, 128 µg/ml, only inhibited one strain, 
J1-177, at pH 6.  All other strains of L. monocytogenes tested grew at the highest nisin 
concentration, which is two to four times the MIC of the free nisin.  The addition of 
EDTA to the emulsion had no effect on the efficacy of the nisin against any of the strains 
tested (Table 4). 
 
Discussion 
The reduction in charge of the primary emulsifier demonstrated in Figure 5 
suggests that the emulsion droplets were successfully coated with the nisin as a 
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 secondary emulsifier.  Caruso and Möhwald (1999) reported a complete charge reversal, 
as measured by ζ- potential, followed the addition of each oppositely charged layer on 
latex particles.  Klinkesorn et al. (2005a), Klindersorn et al. (2005b) and Aoki et al. 
(2005) showed similar changes in ζ- potential when adding layers to emulsion droplets.  
Ogawa et al. (2003) found a small increase in particle diameter following addition of the 
secondary layer similar to the size increase of emulsion droplets upon addition of nisin in 
this study.  
The attachment of the nisin to the protein emulsifier layer greatly decreased its 
antimicrobial efficacy, however.  As previously stated, nisin activity is greatly reduced in 
food products due to the interaction of the antimicrobial with the constituents of the 
product, including lipids (Benech et al., 2002; Ghalfi et al., 2006), salts (Boziaris and 
Nychas, 2006), nitrates (Ghalfi et al., 2006), proteolytic enzymes (Murray and Richard, 
1997; Aasen et al., 2003), and proteins (Aasen et al., 2003; Stergiou et al., 2006).  Aasen 
et al. (2003) showed that more than 80% of the bacteriocins nisin and sakacin P added to 
chicken cold cuts and smoked salmon were absorbed into the protein matrix after 10 
minutes, making them unavailable for antimicrobial activity.  Stergiou et al. (2006) 
showed that lost nisin activity in meat products was due to the formation of bonds 
between nisin and glutathione in proteins.  Though the formation of a secondary nisin 
emulsion layer may have been successful, the binding of the nisin to the pork gelatin 
emulsifier may have caused the loss of antimicrobial activity. 
The loss of nisin activity may also be attributed to the reduction in charge.  Nisin 
activity is most likely charge dependent, with positive lysine residues in the nisin 
molecule interaction with the negatively charged phospholipids head groups in the 
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 membrane (Abee, 1994; Moll et al., 1997).  The nisin molecules used in this study were 
either negatively charged when used at pH 7 (Figure 5 (B)) or have an approximate 
charge of zero when attached to the oil droplets (Figure 6).  Nisin susceptibility tests 
conducted at pH 7 showed no efficacy difference compared to nisin susceptibility at an 
unaltered pH (data not shown).  The net zero charge of the nisin molecule attached to 
emulsion droplet may have reduced the ability of the nisin molecule to interact with the 
bacterial membrane, thus reducing its ability to inhibit the growth of the L. 
monocytogenes strains.  The ability of EDTA to disrupt the outer membrane of Gram-
negative bacteria did not increase the efficacy of the nisin either, further supporting the 
molecules inability to interact with the bacterial membrane. 
 
Conclusions 
 A double layer emulsion was successfully constructed using pork gelatin as a 
cationic primary emulsifier and the food antimicrobial nisin as an anionic secondary 
emulsifier.  The construction of this emulsion, however, greatly reduced the antimicrobial 
efficacy of the nisin, rendering the emulsion unsuitable as a deliver vessel for nisin. 
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 CHAPTER 6 
CONCLUSIONS 
Microbiological contamination is a serious problem for both producers and 
consumers of food products.  L. monocytogenes, in particular, is problematic due to its 
ability to grow under a wide range of conditions and the high mortality rate associated 
with listeriosis.  Though antimicrobials like nisin and lysozyme effectively inhibit the 
growth of this organism, and are approved for food use, the application of these 
compounds to actual food products is problematic.  Constituents of the food interferes 
with the activity of the antimicrobial, greatly decreasing its efficacy.  The focus of this 
study was to devise a method by which these antimicrobials can be delivered into a food 
product without losing activity.  To this end, nisin and lysozyme were attached to silver 
nanoparticles. 
The attachment of lysozyme, an enzyme whose antimicrobial activity is 
dependent upon its enzymatic activity, to the nanoparticles greatly decreased its 
antimicrobial efficacy, most likely due to a conformational change or blocking of the 
active site.  Nisin activity, on the other hand, was significantly increased when attached 
to the metal nanoparticles, suggesting that metal nanoparticles are a viable candidate for 
food antimicrobial delivery.  The increase in efficacy is likely due to the ability of the 
nanoparticles to deliver a concentrated dose of the antimicrobial to the bacterial 
membrane.  Further characterization of the interaction between the antimicrobial nisin 
and the silver nanoparticle and between the loaded silver nanoparticles and the bacteria is 
needed before this increase in efficacy can be fully explained.  Further testing is also 
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 needed to determine if this increased efficacy will still exist when applied to a food 
product.  Since silver is not likely to be an acceptable food additive, a method by which 
these nanoparticles can be used with a food product will need to be determined; addition 
to packaging may be one such option.   
The use of a double layered emulsion as the delivery method for nisin is 
advantageous due to the importance of emulsions in many food products and the all 
natural status of the constituents of the emulsion, in this case corn oil and gelatin.  Using 
gelatin as an emulsifier, however, has proven problematic due to the lose of activity 
observed in nisin when it has bound a protein.  The results of this study support the 
inactivation of nisin by proteins in a food product.  Addition of EDTA to the emulsion 
proved ineffective in the restoration of antimicrobial activity to the molecule.  The ability 
to use a wide array of non-protein emulsifiers, allowing for the testing of numerous 
primary emulsifiers, in the production of emulsions makes this a promising delivery 
method.   
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 CHAPTER 7 
 
TABLES AND FIGURES  
Tables 
 
Table 1.  Particle size of nanoparticle/antimicrobial combinations. 
Concentration Ratio Particle size (nm) 
Nisin 
1:0.167†
1:0.25†
1:0.5†
1:1†
2:1† 
 
Lysozyme 
1:0.167†
1:0.25†
1:0.5†
1:1†
2:1†
290±35 
324±132 
337±132 
283±61 
329±101 
 
 
45±4 
60±10 
160±37 
60±9 
140±15 
†concentration ratio of antimicrobial to nanoparticles in μg/mL
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 Table 2. MIC's (μg/ml) of each silver/nisin concentration against strains of L. 
monocytogenes and E. coli at 32°C after 48 hours. 
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Table 3. MIC (μg/mL) of primary and secondary emulsions against strains of L. 
monocytogenes and E. coli 
 
MIC (μg/mL) 
Emulsion/Nisin Pathogen Nisin Emulsion 
pH 6 pH 7 
L. monocytogenes 
J1-125 
J2-020 
J1-177 
C11-115 
 
E. coli 
35150 
43895 
51685 
700599 
 
32 
>128 
64 
32 
 
 
>128 
>128 
>128 
>128 
 
>128 
>128 
>128 
>128 
 
 
>128 
>128 
>128 
>128 
 
>128 
>128 
  128 
>128 
 
 
>128 
>128 
>128 
>128 
 
>128 
>128 
>128 
>128 
 
 
>128 
>128 
>128 
>128 
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 Table 4. MICs (μg/mL) of secondary emulsions with added EDTA against strains 
of L. monocytogenes and E. coli.
MIC (μg/mL) 
Emulsion/Nisin+EDTA Pathogen EDTA 
512 μg/mL* 256 μg/mL* 
L. monocytogenes 
J1-125 
J2-020 
J1-177 
C11-115 
 
E. coli 
35150 
43895 
51685 
700599 
 
>2048 
>2048 
>2048 
>2048 
 
 
>2048 
>2048 
>2048 
>2048 
 
>128 
>128 
  128 
>128 
 
 
>128 
>128 
>128 
>128 
 
>128 
>128 
>128 
>128 
 
 
>128 
>128 
>128 
>128 
*amount of EDTA in μg/mL added to emulsion containing various concentrations 
of nisin 
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 Figures 
Figure 1.  Growth as measured by OD630 of L. monocytogenes strain Scott A (A) and 
E. coli strain H1730 (B) in the presence of silver nanoparticles at 32°C for 
48 hours. 
 
 
 
(A) 
 
(B) 
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 Figure 2.  Growth as measured by OD630 of L. monocytogenes and E. coli in the 
presence of nisin attached to silver nanoparticles at 32°C for 48 hours. 
   
(A) (B) 
   
(C)      (D) 
 
(A) Strain 101 in the presence of nisin attached to silver nanoparticles at a ratio of 6:1.  
(B) Strain 310 in the presence of nisin attached to silver nanoparticles at a ratio of 6:1. 
(C) Strain Scott A  in the presence of nisin attached to silver nanoparticles at a ratio of 
4:1.  (D) Strain F4546 in the presence of nisin attached to silver nanoparticles at a ratio 
of 6:1.   
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 Figure 3.  Growth as measured by OD630 of L. monocytogenes and E. coli in the 
presence of nisin attached to silver nanoparticles at 20°C for 48 hours. 
 
   
(A) (B) 
   
(C)      (D) 
 
(A) Strain Scott A in the presence of nisin attached to silver nanoparticles at a ratio of 
4:1.  (B) Strain 310 in the presence of nisin attached to silver nanoparticles at a ratio of 
6:1. (C) Strain 310 in the presence of nisin attached to silver nanoparticles at a ratio of 
2:1.  (D) Strain F4546 in the presence of nisin attached to silver nanoparticles at a ratio 
of 6:1.   
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 Figure 4.   Proposed mode of action for increased efficacy of nisin when attached  to 
silver nanoparticles. 
 
 
Nisin molecules attached to silver   Nisin molecule interaction  
Ag 
Ag 
nanoparticle   in bacterial membrane 
 
Nisin molecule structure and hypothesized mode of action adapted from Abee et al. 
(1995) 
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Figure 5. ζ-potential as a function of pH for an emulsion and a nisin solution. 
 
 
 
(A) 
 
 
 
(B) 
 
(A) ζ- potential of the primary emulsion at pH 5 to pH 8.  (B) ζ- potential of a nisin 
solution at pH 2 to pH 9. 
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Figure 6. ζ-Potential of the primary gelatin stabilized emulsion with increasing 
addition of nisin. 
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